FAZIO, GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 12.047
AS - Asia 5.785
EU - Europa 4.971
SA - Sud America 856
Continente sconosciuto - Info sul continente non disponibili 543
AF - Africa 161
OC - Oceania 12
Totale 24.375
Nazione #
US - Stati Uniti d'America 11.442
SG - Singapore 2.150
IT - Italia 1.654
CN - Cina 1.247
HK - Hong Kong 757
RU - Federazione Russa 641
BR - Brasile 615
VN - Vietnam 563
DE - Germania 553
CA - Canada 470
SE - Svezia 454
IE - Irlanda 412
GB - Regno Unito 243
BD - Bangladesh 228
FR - Francia 211
UA - Ucraina 206
IN - India 193
FI - Finlandia 133
ID - Indonesia 95
TR - Turchia 86
AR - Argentina 84
KR - Corea 72
NL - Olanda 72
IQ - Iraq 66
ES - Italia 59
MX - Messico 58
JP - Giappone 56
AT - Austria 54
ZA - Sudafrica 53
PL - Polonia 51
BE - Belgio 48
PH - Filippine 41
DK - Danimarca 40
SA - Arabia Saudita 39
PK - Pakistan 38
EC - Ecuador 36
CH - Svizzera 35
CO - Colombia 35
VE - Venezuela 31
EG - Egitto 20
JM - Giamaica 19
KE - Kenya 19
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 18
CL - Cile 17
GR - Grecia 16
MA - Marocco 16
MY - Malesia 16
CR - Costa Rica 14
CZ - Repubblica Ceca 14
PA - Panama 13
PY - Paraguay 11
AL - Albania 10
ET - Etiopia 10
JO - Giordania 10
LT - Lituania 10
TN - Tunisia 10
AU - Australia 9
AZ - Azerbaigian 9
BO - Bolivia 9
IL - Israele 9
IR - Iran 9
PE - Perù 9
KZ - Kazakistan 8
NP - Nepal 8
RO - Romania 8
BG - Bulgaria 7
OM - Oman 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
DZ - Algeria 6
HU - Ungheria 6
AO - Angola 5
EE - Estonia 5
GT - Guatemala 5
NI - Nicaragua 5
PT - Portogallo 5
TW - Taiwan 5
UY - Uruguay 5
GE - Georgia 4
KG - Kirghizistan 4
NO - Norvegia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
EU - Europa 3
KW - Kuwait 3
LB - Libano 3
NG - Nigeria 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AG - Antigua e Barbuda 2
AM - Armenia 2
BT - Bhutan 2
CG - Congo 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GY - Guiana 2
Totale 23.797
Città #
Ann Arbor 1.479
Singapore 1.306
Ashburn 1.174
San Jose 796
Hong Kong 739
Fairfield 641
Milan 529
Chandler 490
Woodbridge 485
Dublin 403
Wilmington 338
Toronto 336
Houston 323
Frankfurt am Main 316
New York 277
Santa Clara 255
Seattle 254
Beijing 237
Los Angeles 220
Cambridge 212
Council Bluffs 197
Jacksonville 178
Dallas 170
Dearborn 168
Ho Chi Minh City 162
Chicago 160
Hefei 138
Hanoi 134
Princeton 134
The Dalles 123
Rome 100
Buffalo 90
Shanghai 89
Moscow 85
Lauterbourg 84
Nanjing 83
Boardman 72
Seoul 69
Altamura 68
Phoenix 68
Jakarta 65
São Paulo 65
Helsinki 61
Lawrence 60
Munich 60
Lissone 58
Orem 51
Brooklyn 47
Columbus 46
San Diego 46
London 45
Brussels 44
Montreal 44
Denver 42
Atlanta 41
Warsaw 41
Tokyo 38
Guangzhou 35
Vienna 34
Baghdad 33
Nuremberg 33
Chennai 32
Stockholm 31
Lachine 29
Memphis 28
Boston 26
Dong Ket 26
Johannesburg 25
Nanchang 25
Poplar 25
Salt Lake City 25
Haiphong 24
Hangzhou 24
Jinan 23
Monza 23
Turin 23
Zurich 23
Amsterdam 22
Ankara 22
Sesto San Giovanni 22
Brasília 21
Da Nang 21
San Francisco 21
Tianjin 21
Turku 21
Lappeenranta 20
Naples 19
Paris 19
Rio de Janeiro 19
Shenyang 19
Andover 18
Bologna 18
Figino 18
Nairobi 18
Changsha 17
Kocaeli 17
Zhengzhou 17
Fremont 16
Kent 16
Miami 16
Totale 15.021
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 489
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 477
NIPBL: a new player in myeloid cells differentiation 465
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 440
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 437
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 432
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 430
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 409
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 400
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 368
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 366
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 358
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 350
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 348
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 346
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 332
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 329
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 326
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 325
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 321
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 318
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 318
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 313
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 310
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 310
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 308
Characterization of a novel HDAC2 pathogenetic variant: a missing puzzle piece for chromatinopathies 300
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 299
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 293
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 292
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 288
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 286
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 277
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 276
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 276
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 274
Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia 273
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 273
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 272
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 272
Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies 270
Cornelia de Lange Syndrome: NIPBL haploinsufficiency downregulates canonical Wnt pathway in zebrafish embryos and patients fibroblasts 264
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study 263
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 262
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 257
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 257
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 257
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 248
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 243
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 237
Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report 237
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) 236
TEL/ARG induces cytoskeletal abnormalities in 293T cells 235
La proteina di fusione PAX5/TEL altera l’espressione del BCR, la via di segnale di STAT5 e i processi di adesione e migrazione cellulare: studio in un modello in vitro di leucemia linfoblastica acuta 234
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 231
Williams syndrome and mature B-Leukemia: A random association? 229
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 226
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia 226
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia 225
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence 221
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease 221
The role of PAX5 in ALL 221
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype 221
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition 221
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma 215
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis 214
Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia? 214
Unique genomic profile of infant all patients 211
LAL infant introduces a new specific genomic profile 211
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript 211
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 208
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 205
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 204
Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience 202
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 197
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 195
Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects 194
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA 192
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis 191
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia 190
Multivariate Analysis Reveals a miRNA Profile Correlated To Karyotype and Outcome In Pediatric B-Cell Precursor ALL 189
The recombinome of IKZF1 deletions in B-cell precursor ALL 179
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE 178
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 163
PAX5 and C/EBP α/β tole in atypical non-Langerhans cell histiocytic tumor post Acute Lymphoblastic Leukemia 153
Impairment of Retinoic Acid Signaling in Cornelia de Lange Syndrome Fibroblasts 147
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders 138
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials 134
Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study 100
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge 76
A novel highly recurrent fusion circRNA from the kmt2a::aff1 fusion gene impacting mitochondrial metabolism in B-ALL with the t(4;11)(q21.3-q22.1;q23.3) translocation 53
Hematologic Manifestations of Constitutional Trisomy 8 Mosaicism: Two Cases and a Systematic Review of Cytogenetically Confirmed Patients 40
FLT3 AS A NEW THERAPEUTIC TARGET IN PRECLINICAL MODELS OF PEDIATRIC BCP-ALL WITH PAX5 REARRANGEMENT 39
clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL 39
Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report 33
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases 33
Germline and somatic cohesin genes alterations in pediatric acute lymphoblastic leukemia 33
A Gut Feeling: An Exploratory Multi-Omics Study of Gut Microbiome Dysbiosis and Metabolome and Lipidome Alterations in GATA2 Deficiency 32
The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literature 24
Measurable residual disease–dependent unfavorable outcomes in pediatric PAX5-rearranged B-acute lymphoblastic leukemia 20
Totale 24.375
Categoria #
all - tutte 76.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022704 0 0 0 76 66 83 24 61 60 89 65 180
2022/20231.817 184 601 161 148 73 275 19 115 149 6 62 24
2023/20241.369 48 34 62 95 187 356 251 49 88 39 31 129
2024/20253.528 150 362 250 172 320 121 249 94 366 562 312 570
2025/20269.189 1.031 458 614 1.133 1.091 499 1.232 400 627 819 649 636
2026/20272.097 365 559 1.065 108 0 0 0 0 0 0 0 0
Totale 24.375